Studies
Potential Inhibitors for Novel Coronavirus (Covid-19) Protease, March 2020
Therapeutic aspects of taxifolin - An update, Jul-Sep 2017. K. Saftar Asmi, T. Lakshmi, Sri Renukadevi Balusamy, R. Parameswari.
Cardioprotective effects of dihydroquercetin against ischemia reperfusion injury by inhibiting oxidative stress and endoplasmic reticulum stress-induced apoptosis
Taxifolin protects rats against myocardial ischemia/reperfusion injury by modulating the mitochondrial apoptosis pathway, January 2019.
Safety
Taxifolin, also called dyhidro-qercetin, and usual quercetin are relative flavonoids.
Both have a similar mechanism of action inside the cell, but Taxifolin has much higher biological activity and oxidation absorbance level.
Proven safe
15 clinical toxicity studies (acute, sub-acute, and chronic)
8 mutagenicity and genotoxicity studies
Testing showed a dosage of 15,000mg/kg per day can be tolerated.
Small Single Daily Dose
Studies show effective dosage ranges from 20mg to 60mg per day
Exceeding this dose will cause no health risk
Authorities Approval
Recognized as safe by FDA
Approved by EFSA for European Union
Approved by UNCPA for United Kingdom
Coronavirus (Covid19) application
According to a group of scientists from the University of Basel (André Fischer, Manuel Selner, Santos Nerandjan, Markus A. Lille, and Martin Smiesko), Taxifolin is one of the 11 most powerful natural compounds in the world and is the only one directly widely available to consumers that holds the potential to inhibit Covid-19 activity in human cells.
Oxidation is a key process affecting the level of our body's protection from external influences
It is possible to slow down oxidation only with the help of antioxidants
Our body continuously produces antioxidants on its own, but with age it becomes more difficult for it to do so. To stay healthy, you must help your body.
2 ways to help your body
Provoke the production of your own antioxidants with daily physical activity.
Consume as much antioxidants as possible with food.